ReviewBiomolecules2022

Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies.

Nurulhuda Mustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.